Home/Filings/4/0001104659-23-000894
4//SEC Filing

Colon Grace 4

Accession 0001104659-23-000894

CIK 0001640266other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 4:55 PM ET

Size

5.8 KB

Accession

0001104659-23-000894

Insider Transaction Report

Form 4
Period: 2023-01-01
Colon Grace
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-01-01+44,00044,000 total
    Exercise: $6.10Exp: 2033-01-01Common Stock (44,000 underlying)
Footnotes (1)
  • [F1]This stock option was issued pursuant to the 2015 Stock Option and Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the "Vesting Commencement Date") of the option is the grant date. The option vests over four years, with 1/16th of the shares of common stock underlying the option vesting upon the three-month anniversary of the Vesting Commencement Date and an additional 1/16th of the shares of common stock underlying the option vesting at the end of each successive three-month period thereafter, subject to the Reporting Person's continued service as a director.

Issuer

Voyager Therapeutics, Inc.

CIK 0001640266

Entity typeother

Related Parties

1
  • filerCIK 0001780354

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:55 PM ET
Size
5.8 KB